Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Aurobindo Pharma Ltd
Press Release Jul 04 2023
Business
Jul 4 2023
5 min read

Press Release Jul 04 2023

Aurobindo Pharma Limited has informed the Exchange regarding a press release dated July 04, 2023, titled "CuraTeQ Biologics announces positive result in phase 3 clinical trial for its proposed Trastuzumab Biosimilar product.".

View Attachment